Clinical Trial Update: Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

View source ↗

Summary

This clinical trial update describes the biodistribution of the PET tracer [11C]PIB in participants with risk factors for Alzheimer's disease, with enrollment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• [11C]PIB (Pittsburgh compound-B)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: ENROLLING_BY_INVITATION